GRPZ Fact Sheet: Invesco S&P SmallCap 600 GARP ETF
Share
$31.38
close, Nov 18, 2026
Over the year to Nov 18, 2026, GRPZ returned +24.3% in total and charged 0.35% a year.
- 1-year total return
- +24.3%
- to Nov 18, 2026
- Expense ratio
- 0.35%
- a year
- Net assets
- $3.1m
- on Nov 17, 2026
- Net flow, last 5 trading days
- $0
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
GRPZ $12,433 +24.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+1.6%
3 months−5.7%
Year to date+18.9%
1 year+24.3%
Since launch+27.8%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
ADMA Biologics Inc2.61%
Palomar Holdings Inc2.25%
TG Therapeutics Inc2.17%
Inspire Medical Systems Inc2.17%
TransMedics Group Inc2.15%
Sezzle Inc2.14%
QuinStreet Inc1.92%
Millrose Properties Inc1.86%
Paycom Software Inc1.83%
Progyny Inc1.68%
GRPZ top ten by weight, 20.8% of the fund, of its 88 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P SmallCap 600 GARP Index · First traded Mar 27, 2024 · Benchmark Its own holdings, as of Nov 17, 2026